Pathnostics
1 known investors
Pathnostics is a CAP-accredited and CLIA-certified diagnostics laboratory offering histopathology, cytology, and molecular tests across urology, women's health, and gastroenterology. Its flagship platform, Guidance UTI, combines molecular detection with proprietary Pooled Antibiotic Susceptibility Testing (P-AST) for infectious disease and cancer diagnostics.
BiotechDigital HealthMedical Devices
Founders & leadership
DP
David PauluzziChief Executive Officer & Co-Founder
Investors · 1
Competitors · 3
by search overlapMedscape466 shared keywordsMedscape is an online medical information platform providing clinical news, expert perspectives, case studies, quizzes, and reference material across specialties such as cardiology, oncology, neurology, and psychiatry. It serves physicians, nurses, pharmacists, residents, and medical students.
Osmosis254 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
Oup232 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
Companies competing with Pathnostics for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Pathnostics do?
- Pathnostics is a CAP-accredited and CLIA-certified diagnostics laboratory offering histopathology, cytology, and molecular tests across urology, women's health, and gastroenterology. Its flagship platform, Guidance UTI, combines molecular detection with proprietary Pooled Antibiotic Susceptibility Testing (P-AST) for infectious disease and cancer diagnostics.
- Who founded Pathnostics?
- Pathnostics was founded by David Pauluzzi.
- Who are Pathnostics's investors?
- Pathnostics's investors include JSD Capital, LLC.